These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 36884083)

  • 101. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 103. PD-1 Status in CD8
    Kansy BA; Concha-Benavente F; Srivastava RM; Jie HB; Shayan G; Lei Y; Moskovitz J; Moy J; Li J; Brandau S; Lang S; Schmitt NC; Freeman GJ; Gooding WE; Clump DA; Ferris RL
    Cancer Res; 2017 Nov; 77(22):6353-6364. PubMed ID: 28904066
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
    Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
    Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
    World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
    Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis.
    Polesel J; Menegaldo A; Tirelli G; Giacomarra V; Guerrieri R; Baboci L; Casarotto M; Lupato V; Fanetti G; Boscolo-Rizzo P; Fratta E
    Front Oncol; 2021; 11():787864. PubMed ID: 34900743
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
    Justesen MM; Jakobsen KK; Bendtsen SK; Garset-Zamani M; Mordhorst C; Carlander AF; Gothelf AB; Grønhøj C; von Buchwald C
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680237
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
    Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
    Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
    [TBL] [Abstract][Full Text] [Related]  

  • 110. HPV Infection in Squamous Cell Carcinoma of the Hypopharynx, Larynx, and Oropharynx With Multisite Involvement.
    Kuga R; Yamamoto H; Jiromaru R; Hongo T; Yasumatsu R; Matsuo M; Hashimoto K; Taniguchi M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2023 Sep; 47(9):955-966. PubMed ID: 37357948
    [TBL] [Abstract][Full Text] [Related]  

  • 111. An integrated model for prognosis in vulvar squamous cell carcinoma.
    Zhang T; Zhu Y; Luo J; Li J; Niu S; Chen H; Zhou F
    BMC Cancer; 2023 Jun; 23(1):534. PubMed ID: 37308869
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis.
    Xu B; Saliba M; Alzumaili B; Alghamdi M; Lee N; Riaz N; Patel SG; Ganly I; Dogan S; Ghossein RA; Katabi N
    Mod Pathol; 2022 Nov; 35(11):1578-1586. PubMed ID: 35690646
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Cause of Death in Patients with Oropharyngeal Carcinoma by Human Papillomavirus Status: Comparative Data Analysis.
    Zhang DD; Lei M; Wang Y; Zeng PJ; Hong YJ; Cai CF
    JMIR Public Health Surveill; 2023 Aug; 9():e47579. PubMed ID: 37642982
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
    Lin CM; Lin LW; Chen YW; Ye YL
    Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8 + T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in China.
    Zhang C; Zhang G; Xue L; Zhang Z; Zeng Q; Wu P; Wang L; Yang Z; Zheng B; Tan F; Xue Q; Gao S; Sun N; He J
    Int J Surg; 2024 Jul; 110(7):4297-4309. PubMed ID: 36974732
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration.
    Wilde DC; Castro PD; Bera K; Lai S; Madabhushi A; Corredor G; Koyuncu C; Lewis JS; Lu C; Frederick MJ; Frederick AM; Haugen AE; Zevallos JP; Sturgis EM; Shi J; Huang AT; Hernandez DJ; Skinner HD; Kemnade JO; Yu W; Sikora AG; Sandulache VC
    Mod Pathol; 2022 Aug; 35(8):1045-1054. PubMed ID: 35184149
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
    Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
    J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors.
    Stern PL; Dalianis T
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202255
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Evaluation of programmed cell death ligand 1 expression in a contemporary cohort of penile squamous cell carcinoma and its correlation with clinicopathologic and survival parameters: A study of 134 patients.
    Lobo A; Mishra SK; Jha S; Tiwari A; Kapoor R; Sharma S; Kaushal S; Kiranmai NS; Das MR; Peddinti KP; Sharma SK; Bhardwaj N; Arora S; Jain D; Jain E; Munjal G; Shinde S; Malik V; Singh H; Varshney J; Pradhan D; Dixit M; Pattnaik N; Sharma AK; Barapatre YR; Pradhan M; Satapathy K; Rath D; Jaiswal S; Das S; Khadenga C; Routa S; Baisakh MR; Tiwari R; Sampat NY; Chakrabarti I; Parwani AV; Mohanty SK
    Am J Clin Pathol; 2024 Jan; 161(1):49-59. PubMed ID: 37639681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.